tiprankstipranks
Telix Pharmaceuticals Ltd. (AU:TLX)
ASX:TLX
Australian Market

Telix Pharmaceuticals Ltd. (TLX) Financial Statements

Compare
247 Followers

Telix Pharmaceuticals Ltd. Financial Overview

Telix Pharmaceuticals Ltd.'s market cap is currently $9.18B. The company's EPS TTM is AU$0.15; its P/E ratio is 180.64; Telix Pharmaceuticals Ltd. is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is AU$0.14. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total RevenueAU$ 496.66MAU$ 160.10MAU$ 7.60MAU$ 5.21MAU$ 3.48M
Gross ProfitAU$ 308.50MAU$ 29.34MAU$ -29.77MAU$ -16.88MAU$ -11.88M
Operating IncomeAU$ 51.89MAU$ -73.18MAU$ -81.25MAU$ -49.25MAU$ -40.26M
EBITDAAU$ 22.97MAU$ -92.84MAU$ -70.07MAU$ -44.94MAU$ -36.17M
Net IncomeAU$ 5.21MAU$ -104.08MAU$ -80.51MAU$ -44.89MAU$ -27.87M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 123.24MAU$ 116.33MAU$ 22.04MAU$ 77.94MAU$ 44.60M
Total AssetsAU$ 398.30MAU$ 260.59MAU$ 109.81MAU$ 164.44MAU$ 102.61M
Total DebtAU$ 17.45MAU$ 10.45MAU$ 2.54MAU$ 2.21MAU$ 2.13M
Net DebtAU$ -105.79MAU$ -105.88MAU$ -19.50MAU$ -75.74MAU$ -42.47M
Total LiabilitiesAU$ 249.39MAU$ 178.44MAU$ 106.17MAU$ 84.44MAU$ 31.88M
Stockholders' EquityAU$ 148.91MAU$ 80.01MAU$ 2.16MAU$ 79.02MAU$ 70.08M
Cash Flow
Free Cash FlowAU$ 13.09MAU$ -77.83MAU$ -60.67MAU$ 1.64MAU$ -23.80M
Operating Cash FlowAU$ 23.88MAU$ -63.97MAU$ -59.33MAU$ 1.96MAU$ -23.33M
Investing Cash FlowAU$ -25.49MAU$ -17.00MAU$ -2.73MAU$ -1.09MAU$ -468.00K
Financing Cash FlowAU$ 10.19MAU$ 174.96MAU$ 2.85MAU$ 34.12MAU$ 42.72M
Currency in AUD

Telix Pharmaceuticals Ltd. Earnings and Revenue History

Telix Pharmaceuticals Ltd. Debt to Assets

Telix Pharmaceuticals Ltd. Cash Flow

Telix Pharmaceuticals Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis